Oxidative stress in obstructive nephropathy.

TGF-β signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal (2012) 1.82

Induction of oxidative stress in kidney. Int J Nephrol (2012) 1.12

Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis. Am J Physiol Renal Physiol (2012) 1.03

Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2. Nutr Metab (Lond) (2014) 0.94

Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy. Am J Physiol Renal Physiol (2014) 0.91

Chitosan/siRNA nanoparticles targeting cyclooxygenase type 2 attenuate unilateral ureteral obstruction-induced kidney injury in mice. Theranostics (2015) 0.90

Protective role of female gender in programmed accelerated renal aging in the rat. Physiol Rep (2015) 0.89

Cyclic nucleotide signalling in kidney fibrosis. Int J Mol Sci (2015) 0.80

Fimasartan, a Novel Angiotensin-Receptor Blocker, Protects against Renal Inflammation and Fibrosis in Mice with Unilateral Ureteral Obstruction: the Possible Role of Nrf2. Int J Med Sci (2015) 0.80

Alpha-lipoic acid attenuates renal injury in rats with obstructive nephropathy. Biomed Res Int (2013) 0.79

Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci Rep (2017) 0.79

Epac-Rap signaling reduces oxidative stress in the tubular epithelium. J Am Soc Nephrol (2014) 0.79

Screening and identification of the differential proteins in kidney with complete unilateral ureteral obstruction. Int J Clin Exp Pathol (2015) 0.78

Alleviation of kidney damage induced by unilateral ureter obstruction in rats by Rhodiola rosea. J Endourol (2013) 0.77

Mediators and mechanisms of heat shock protein 70 based cytoprotection in obstructive nephropathy. Cell Stress Chaperones (2015) 0.76

Protective effect of hydrogen sulfide on renal injury in the experimental unilateral ureteral obstruction. Int Braz J Urol (2016) 0.75

15-Deoxy-Δ(12,14)-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction. Mediators Inflamm (2017) 0.75

Wt-1 Expression Linked to Nitric Oxide Availability during Neonatal Obstructive Nephropathy. Adv Urol (2013) 0.75

C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease. Oncotarget (2016) 0.75

Regulation of MUTYH, a DNA Repair Enzyme, in Renal Proximal Tubular Epithelial Cells. Oxid Med Cell Longev (2015) 0.75

Heat shock protein 70/nitric oxide effect on stretched tubular epithelial cells linked to WT-1 cytoprotection during neonatal obstructive nephropathy. Int Urol Nephrol (2017) 0.75

Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43

The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 14.96

NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62

NADPH oxidase: an update. Blood (1999) 7.65

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet (1995) 7.34

Non-Smad pathways in TGF-beta signaling. Cell Res (2009) 5.54

Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int (2006) 4.87

Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest (2003) 4.58

The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med (1995) 4.25

Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A (2000) 4.24

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int (2009) 4.02

BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev (2005) 3.97

NADPH oxidase. Curr Opin Immunol (2004) 3.58

Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol (2002) 3.44

Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol (1994) 3.23

NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care (2008) 3.07

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol (2008) 2.83

Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev (1998) 2.56

Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes (2007) 2.51

Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem Biophys Res Commun (1998) 2.43

Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol (2005) 2.18

TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci (2004) 2.17

NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension (2006) 1.99

Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97

Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J Am Soc Nephrol (2003) 1.84

Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int (2005) 1.83

NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80

Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int (2003) 1.78

NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol (2005) 1.78

Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int (2005) 1.78

Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int (2008) 1.78

Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension (2002) 1.73

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J Clin Invest (2002) 1.70

Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol (2004) 1.70

Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction. Kidney Int (2004) 1.69

Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol (2001) 1.67

Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int (2003) 1.61

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol Renal Physiol (2000) 1.61

Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60

Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J Hypertens (2008) 1.57

Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int (2005) 1.57

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant (2008) 1.56

Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension (2009) 1.55

Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol (2004) 1.55

Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation (2006) 1.50

Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2001) 1.46

Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci U S A (2009) 1.44

Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem (2008) 1.43

Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A (2004) 1.41

Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal (2008) 1.32

D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.32

NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 1.31

Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol (1981) 1.30

Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int (2006) 1.30

Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol (2004) 1.29

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int (2007) 1.25

Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int (1988) 1.22

New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett (2003) 1.20

Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol (2003) 1.18

Role of superoxide in modulating the renal effects of angiotensin II. Hypertension (2003) 1.16

Impact of androgen-induced oxidative stress on hypertension in male SHR. Am J Physiol Regul Integr Comp Physiol (2006) 1.16

Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int (2009) 1.15

Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens (2005) 1.13

The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J Am Soc Nephrol (2004) 1.12

Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant (2008) 1.11

Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol (2004) 1.11

Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology (2008) 1.08

Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. Lab Invest (1973) 1.08

Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int (1999) 1.08

Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest (1999) 1.07

NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell Physiol Biochem (2009) 1.07

Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int (1994) 1.07

Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl (2003) 1.06

Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant (2005) 1.06

Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases. Kidney Int (2001) 1.05

Apocynin inhibits peroxynitrite formation by murine macrophages. Br J Pharmacol (2000) 1.04

Oxidative stress contributes to renovascular hypertension. Am J Hypertens (2008) 1.01

Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol (2008) 1.01

Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol (2004) 1.00

A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol (2008) 0.99

Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cell Mol Biol (Noisy-le-grand) (2005) 0.99

Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant (2005) 0.98

CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis. J Am Soc Nephrol (2006) 0.98

Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. J Physiol Pharmacol (2006) 0.98

Finding partners: how BMPs select their targets. Dev Dyn (2009) 0.97

Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol (2002) 0.97

Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int (2001) 0.97

Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens (2006) 0.96

Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab Invest (2008) 0.96

Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol Dial Transplant (2005) 0.96

Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension (2008) 0.95

Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol (2006) 0.95

Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology (2007) 0.95

The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. J Nephrol (2003) 0.94

The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol Appl Pharmacol (2007) 0.93

C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J Am Soc Nephrol (2009) 0.93

Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J Endourol (2009) 0.92

Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am J Nephrol (2007) 0.92

Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Res Clin Pract (2008) 0.92

Out, damned dot: studies of the NADPH oxidase in atherosclerosis. J Clin Invest (2001) 0.91

FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res (2007) 2.69

Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol (2002) 2.45

Protein restriction in lactation confers nephroprotective effects in the male rat and is associated with increased antioxidant expression. Am J Physiol Regul Integr Comp Physiol (2007) 2.15

The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J (2004) 2.09

CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int (2002) 1.77

Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis Rheum (2007) 1.69

The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS One (2008) 1.68

Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest (2012) 1.66

Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support. Eur J Heart Fail (2012) 1.64

Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. J Hypertens (2011) 1.52

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy. Kidney Int (2005) 1.52

Fibrin-thrombin coated sealant increases strength of esophagogastric anastomoses in a rat model. J Surg Res (2012) 1.43

Can exercise prevent preeclampsia? J Hypertens (2010) 1.40

Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One (2012) 1.36

Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol (2004) 1.36

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol (2012) 1.33

Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol (2013) 1.30

Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species. Cell Signal (2013) 1.29

Tetrahydrobiopterin, but not L-arginine, decreases NO synthase uncoupling in cells expressing high levels of endothelial NO synthase. Hypertension (2005) 1.29

Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol (2003) 1.28

Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology. Clin Exp Pharmacol Physiol (2013) 1.28

Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2006) 1.20

In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent. Nephrol Dial Transplant (2005) 1.20

CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol (2008) 1.19

Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye. Arch Ophthalmol (2006) 1.18

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy. Diabetes Care (2008) 1.18

How to screen non-viral gene delivery systems in vitro? J Control Release (2011) 1.17

Connective tissue growth factor and igf-I are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes (2003) 1.16

Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant (2007) 1.13

Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11

Effect of VEGF-A on expression of profibrotic growth factor and extracellular matrix genes in the retina. Invest Ophthalmol Vis Sci (2007) 1.10

Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. J Histochem Cytochem (2007) 1.10

Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J Clin Invest (2010) 1.09

Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction. Dev Dyn (2004) 1.08

Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens (2009) 1.08

Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? Pharm Res (2008) 1.07

Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension (2007) 1.07

Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice. Am J Physiol Renal Physiol (2005) 1.06

Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care (2004) 1.05

BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression. J Histochem Cytochem (2009) 1.04

Reduction of fibrosis-related arrhythmias by chronic renin-angiotensin-aldosterone system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol (2010) 1.04

Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis. Am J Pathol (2011) 1.03

CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy. J Pathol (2011) 1.02

Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension (2004) 1.02

Targeting podocyte-associated diseases. Adv Drug Deliv Rev (2010) 1.01

Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol (2005) 1.01

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00

c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation. J Pharmacol Exp Ther (2009) 0.99

Target organ cross talk in cardiorenal syndrome: animal models. Am J Physiol Renal Physiol (2012) 0.99

Reduced Cx43 expression triggers increased fibrosis due to enhanced fibroblast activity. Circ Arrhythm Electrophysiol (2012) 0.98

Systemic arterial and venous determinants of renal hemodynamics in congestive heart failure. Heart Fail Rev (2012) 0.98

Bone-marrow-derived cells contribute to endothelial repair after thrombotic microangiopathy. Blood (2002) 0.97

Allelic depletion of grem1 attenuates diabetic kidney disease. Diabetes (2009) 0.97

Connective tissue growth factor (CTGF/CCN2) is increased in peritoneal dialysis patients with high peritoneal solute transport rate. Am J Physiol Renal Physiol (2009) 0.97

Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease. Cell Transplant (2012) 0.97

Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers (2011) 0.97

Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am J Physiol Renal Physiol (2006) 0.96

Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis. FASEB J (2011) 0.96

Connective tissue growth factor is necessary for retinal capillary basal lamina thickening in diabetic mice. J Histochem Cytochem (2008) 0.95

Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats. Am J Physiol Endocrinol Metab (2011) 0.93

Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension (2004) 0.92

IFN gamma-dependent SOCS3 expression inhibits IL-6-induced STAT3 phosphorylation and differentially affects IL-6 mediated transcriptional responses in endothelial cells. Am J Physiol Cell Physiol (2010) 0.92

Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. Am J Physiol Renal Physiol (2009) 0.92

Nitric oxide-dependent and nitric oxide-independent transcriptional responses to high shear stress in endothelial cells. Hypertension (2005) 0.92

Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant (2004) 0.91

A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.91

Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet (2013) 0.90

Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol (2010) 0.90

Early determinants of cardiovascular disease. Best Pract Res Clin Endocrinol Metab (2012) 0.89

The Caenorhabditis elegans NR4A nuclear receptor is required for spermatheca morphogenesis. Dev Biol (2007) 0.89

Could aging human skin use a connective tissue growth factor boost to increase collagen content? J Invest Dermatol (2010) 0.88

Blood pressure in mutant rats lacking the 5-hydroxytryptamine transporter. Hypertension (2006) 0.88

Hypercholesterolemia in rats induces podocyte stress and decreases renal cortical nitric oxide synthesis via an angiotensin II type 1 receptor-sensitive mechanism. J Am Soc Nephrol (2004) 0.88

Erythropoietin treatment in patients with combined heart and renal failure: objectives and design of the EPOCARES study. J Nephrol (2010) 0.87

Direct visualization of Smad1/5/8-mediated transcriptional activity identifies podocytes and collecting ducts as major targets of BMP signalling in healthy and diseased kidneys. J Pathol (2011) 0.87